Live Pharma Import data of Philippines imports from thailand under HS Code 300490 via Port Manila-int'l-container-port , our Philippines customs import data reports include date, value, quantity, product description, HS code, port, country, and Philippines pharma importers data
| Date |
HS Code |
Product Description |
Origin Country |
Custom Name |
QTY. |
Unit |
Weight |
Importer Name |
|---|---|---|---|---|---|---|---|---|
| 2024-11-22 00:00:00 |
30049099000
|
PHARMACEUTICAL PRODUCTS-CICLODIN TABLET 500 MG(CIPROFLOXACIN(AS HYDROCHLORIDE) | THAILAND | Manila Int'l Container Port | 1077.79 | Kilogram | 46689.06 | Importer Name |
| 2024-11-22 00:00:00 |
30049099000
|
PHARMACEUTICAL PRODUCTS-IRBEZ 150 TABLET(IRBESARTAN) | THAILAND | Manila Int'l Container Port | 516.19 | Kilogram | 91287.62 | Importer Name |
| 2024-11-22 00:00:00 |
30049099000
|
PHARMACEUTICAL PRODUCTS-REBAMID 100 TABLET(REBAMIPIDE) | THAILAND | Manila Int'l Container Port | 188.34 | Kilogram | 24012.34 | Importer Name |
| 2024-11-22 00:00:00 |
30049099000
|
1X40 CONT STC PHARMACEUTICAL PRODUCT 91021X 1X1 VIAL ZEFXON INJECTION | THAILAND | Manila Int'l Container Port | 4095.95 | Kilogram | 128220.04 | Importer Name |
| 2024-11-13 00:00:00 |
30049099000
|
1X40 CONT STC PHARMACEUTICAL PRODUCT 22071X 1X20X6S CALVIN PLUS TABLET | THAILAND | Manila Int'l Container Port | 6621.3 | Kilogram | 137791.87 | Importer Name |
| 2024-11-29 00:00:00 |
30049099000
|
PHARMACEUTICAL PRODUCTS-TORAMIG 25 TABLET(TOPIRAMATE) | THAILAND | Manila Int'l Container Port | 95.06 | Kilogram | 23254.26 | Importer Name |
| 2024-11-29 00:00:00 |
30049099000
|
PHARMACEUTICAL PRODUCTS-NERVICA 150 CAPSULE(PREGABALIN) | THAILAND | Manila Int'l Container Port | 67.78 | Kilogram | 16262.63 | Importer Name |
| 2024-11-29 00:00:00 |
30049099000
|
PHARMACEUTICAL PRODUCTS-GLYCENIL MR 60 TABLET(GLICLAZIDE) | THAILAND | Manila Int'l Container Port | 203.88 | Kilogram | 11783.11 | Importer Name |
| 2024-11-22 00:00:00 |
30049099000
|
PHARMACEUTICAL PRODUCTS-LIPIDUCE 160 TABLET(FENOFIBRATE) | THAILAND | Manila Int'l Container Port | 1312.26 | Kilogram | 108064.49 | Importer Name |
2024-11-22 00:00:00
PHARMACEUTICAL PRODUCTS-CICLODIN TABLET 500 MG(CIPROFLOXACIN(AS HYDROCHLORIDE)
1077.79
Kilogram
46689.06
2024-11-22 00:00:00
PHARMACEUTICAL PRODUCTS-IRBEZ 150 TABLET(IRBESARTAN)
516.19
Kilogram
91287.62
2024-11-22 00:00:00
PHARMACEUTICAL PRODUCTS-REBAMID 100 TABLET(REBAMIPIDE)
188.34
Kilogram
24012.34
2024-11-22 00:00:00
1X40 CONT STC PHARMACEUTICAL PRODUCT 91021X 1X1 VIAL ZEFXON INJECTION
4095.95
Kilogram
128220.04
2024-11-13 00:00:00
1X40 CONT STC PHARMACEUTICAL PRODUCT 22071X 1X20X6S CALVIN PLUS TABLET
6621.3
Kilogram
137791.87
2024-11-29 00:00:00
PHARMACEUTICAL PRODUCTS-TORAMIG 25 TABLET(TOPIRAMATE)
95.06
Kilogram
23254.26
2024-11-29 00:00:00
PHARMACEUTICAL PRODUCTS-NERVICA 150 CAPSULE(PREGABALIN)
67.78
Kilogram
16262.63
2024-11-29 00:00:00
PHARMACEUTICAL PRODUCTS-GLYCENIL MR 60 TABLET(GLICLAZIDE)
203.88
Kilogram
11783.11
2024-11-22 00:00:00
PHARMACEUTICAL PRODUCTS-LIPIDUCE 160 TABLET(FENOFIBRATE)
1312.26
Kilogram
108064.49
The database includes shipment-level information such as shipment date, HS code, product description, quantity, value, port details, country of origin & destination, & importer-exporter information for accurate trade analysis of products under HS code 300490 for Philippines pharma imports from Thailand via Port Manila-int'l-container-port.
Port Manila-int'l-container-port typically refers to a port that is used for handling and forwarding shipments into Philippines, making it important for tracking inland and cross-border trade flows.
It helps businesses understand sourcing patterns, evaluate supplier performance, track pricing trends, and identify demand for pharma products, enabling better decision-making for trade and market expansion for Philippines pharma imports from thailand under HS code 300490 via Port Manila-int'l-container-port.
Businesses can identify key importers, evaluate supplier competitiveness, track pricing trends, and analyze demand for specific rubber products to make strategic sourcing and expansion decisions.
Importers, exporters, traders, manufacturers, and market analysts can use this data to understand trade patterns, optimize supply chains, identify potential partners, and gain a competitive advantage in the pharma market.
